Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 9.4.2024Viatris Limited (VIM)7043AEplerenon Viatris 50 mg filmom obalené tablety (tbl flm 30x50 mg (fľ.HDPE))24.4.2024R
 15.4.2024Zentiva, k.s. (ZNT-1)4238EDiozen Forte (tbl flm 90x1000 mg (blis.PVC/Al))24.4.2024U
 18.4.2024KRKA, d.d., Novo mesto (KRK-2)89445Co-Prenessa 8 mg/2,5 mg (tbl 90x8 mg/2,5 mg (blis.OPA/Al/PVC/Al))22.4.2024R
 18.4.2024KRKA, d.d., Novo mesto (KRK-2)86104Karbis 8 mg tablety (tbl 28x8 mg (blis.PVC/PVDC/Al))22.4.2024R
 18.4.2024KRKA, d.d., Novo mesto (KRK-2)43974Kventiax 100 mg (tbl flm 30x100 mg (blis.PVC/Al))22.4.2024R
 18.4.2024KRKA, d.d., Novo mesto (KRK-2)8191DApeneta 150 mg tablety s predĺženým uvoľňovaním (tbl plg 60(2x30)x150 mg (fľ.HDPE))22.4.2024O
 18.4.2024KRKA, d.d., Novo mesto (KRK-2)04619Atoris 30 (tbl flm 30x30 mg (blis.OPA/Al/PVC/Al))22.4.2024O
 18.4.2024KRKA, d.d., Novo mesto (KRK-2)05116Monkasta 5 mg žuvacie tablety (tbl mnd 100x5 mg (blis.OPA/Al/PVC/Al))22.4.2024O
 5.4.2024ratiopharm GmbH (RAT)36302Fentanyl ratiopharm 25 µg/h (emp tdm 5x25 µg/1 h (vre.papier/PE/Al/surlyn))22.4.2024R
 5.4.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)37256Cabest 0,5 mg (tbl 8x0,5 mg (fľ.skl.hnedá))19.4.2024R
 5.4.2024Teva B.V. (TEV-NL-4)95236Sertralin Actavis 100 mg (tbl flm 30x100 mg (blis.PVC/Al))19.4.2024R
 17.4.2024Baxalta Innovations GmbH (BXA)1888CCuvitru 200 mg/ml (sol inj 1x5 ml (liek.inj.skl.))17.4.2024O
 17.4.2024B.Braun Melsungen AG (BME)5716ARingerfundin (sol inf 10x500 ml (fľ.PE))17.4.2024R
 17.4.2024Bausch + Lomb Ireland Limited (BUS)4059BBrizadopt 10 mg/ml (int opu 3x5 ml/50 mg (fľ.LDPE))17.4.2024O
 17.4.2024Laboratories THEA (LTH)76499Spersadex comp. (int opo 1x5 ml (fľ.LDPE))17.4.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To